Evidence map›Paper›PMID 39953321›Full record

ArticleAnalytical and bioanalytical chemistry2025

An ultra-fast method for therapeutic drug monitoring of tacrolimus, sirolimus and cyclosporine A.

Zhi-Hua Lv, Xin Li, Rui Peng, Shao-Ting Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Rapid analysis of narrow therapeutic index drugs by sonic spray ionization mass spectrometry.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhi-Hua Lv *Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Xin Li *Department of Laboratory Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, 225300, Jiangsu, China.
Rui Peng *Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Shao-Ting WangDepartment of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China. shaotingw@whu.edu.cn.ORCID http://orcid.org/0000-0001-9976-0445

Funding

Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University JCRCFZ-2022-001Open Research Fund of Hubei Key Laboratory 2021KFY026The Youth Key Talent Program of Renmin Hospital of Wuhan University RMQNZD2024003
6 · The paper itself

Abstract

Therapeutic drug monitoring for immunosuppressants is a widely conducted global practice. Traditionally, the pretreatment of whole blood involves the use of metal ions combined with organic solvents. However, this method requires multiple reagent additions, repeated opening, closing, and vortexing of vials, and it also leads to heavy metal pollution. Given the typically large sample volumes, optimizing this process is crucial for increasing throughput, reducing the workload of clinical staff, and lowering costs. We discovered that treating whole blood with a 60 to 75% acetonitrile (ACN) solution effectively releases tacrolimus, sirolimus, and cyclosporine A while simultaneously precipitating protein. This allowed us to significantly simplify the pretreatment process to just adding 65% ACN solution containing internal standards, manually shaking for 20 s, and centrifuging for 2 min. The resulted supernatant can then be directly analyzed by mass spectrometry. Method validation demonstrated that the new approach can accurately quantify tacrolimus in the range of 0.64 to 37.5 ng/ml, cyclosporine A at 12 to 976 ng/ml, and sirolimus at 0.99 to 43.4 ng/ml. A comparison of paired samples showed the new method to be perfectly consistent with the classical method, with 293 out of 300 results deviating by no more than ± 20%. This study has greatly simplified the workflow, increased throughput, and resolved environmental concerns for therapeutic drug monitoring of immunosuppressants, including tacrolimus, sirolimus, and cyclosporine A, in whole blood samples. The proposed method is a viable replacement for existing protocols and deserves to be adopted in all clinical laboratories with relevant practical needs globally.

Indexed as

CyclosporineDrug MonitoringImmunosuppressive AgentsSirolimusTacrolimusAcetonitrilesHumansLimit of DetectionReproducibility of ResultsTandem Mass SpectrometryAcetonitrilesCyclosporineImmunosuppressive AgentsSirolimusTacrolimusCyclosporine ALC-MSSirolimusTacrolimusTherapeutic drug monitoring

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.